The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Quantum Dot−Aptamer Conjugates for Synchronous Cancer Imaging, Therapy, and Sensing of Drug Delivery Based on Bi-Fluorescence Resonance Energy Transfer
Abstract
We report a novel quantum dot (QD)-aptamer(Apt)-doxorubicin (Dox) conjugate [QD-Apt(Dox)] as a targeted cancer imaging, therapy, and sensing system. By functionalizing the surface of fluorescent QD with the A10 RNA aptamer, which recognizes the extracellular domain of the prostate specific membrane antigen (PSMA), we developed a targeted QD imaging system (QD-Apt) that is capable of differential uptake and imaging of prostate cancer cells that express the PSMA protein. The intercalation of Dox, a widely used antineoplastic anthracycline drug with fluorescent properties, in the double-stranded stem of the A10 aptamer results in a targeted QD-Apt(Dox) conjugate with reversible self-quenching properties based on a Bi-FRET mechanism. A donor-acceptor model fluorescence resonance energy transfer (FRET) between QD and Dox and a donor-quencher model FRET between Dox and aptamer result when Dox intercalated within the A10 aptamer. This simple multifunctional nanoparticle system can deliver Dox to the targeted prostate cancer cells and sense the delivery of Dox by activating the fluorescence of QD, which concurrently images the cancer cells. We demonstrate the specificity and sensitivity of this nanoparticle conjugate as a cancer imaging, therapy and sensing system in vitro.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics
Michalet, X., Pinaud, F. F., Bentolila, L. A., Tsay, J. M., Doose, S., Li, J. J., Sundaresan, G., Wu, A. M., Gambhir, S. S., & Weiss, S. (2005) · Science · doi:10.1126/science.1104274 · Cited by 7,790
Quantum dot bioconjugates for imaging, labelling and sensing
Medintz, I. L., Uyeda, H. T., Goldman, E. R., & Mattoussi, H. (2005) · Nature Materials · doi:10.1038/nmat1390 · Cited by 6,229
Self-assembled nanoscale biosensors based on quantum dot FRET donors
Medintz, I. L., Clapp, A. R., Mattoussi, H., Goldman, E. R., Fisher, B., & Mauro, J. M. (2003) · Nature Materials · doi:10.1038/nmat961 · Cited by 1,601
Nanoparticle-Aptamer Bioconjugates
Farokhzad, O. C., Jon, S., Khademhosseini, A., Tran, T.-N. T., LaVan, D. A., & Langer, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2550 · Cited by 897
Self-citationDNA-based therapeutics and DNA delivery systems: A comprehensive review
Patil, S. D., Rhodes, D. G., & Burgess, D. J. (2005) · The AAPS Journal · doi:10.1208/aapsj070109 · Cited by 630
An Aptamer–Doxorubicin Physical Conjugate as a Novel Targeted Drug‐Delivery Platform
Bagalkot, V., Farokhzad, O. C., Langer, R., & Jon, S. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200602251 · Cited by 613
Self-citationLupold, S. E., Hicke, B. J., Lin, Y. H., & Coffey, D. S. (2002) · PubMed · Cited by 566
A FRET-Based Approach to Ratiometric Fluorescence Detection of Hydrogen Peroxide
Albers, A. E., Okreglak, V. S., & Chang, C. J. (2006) · Journal of the American Chemical Society · doi:10.1021/ja063308k · Cited by 375
Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference
Tan, W. B., Jiang, S., & Zhang, Y. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.11.018 · Cited by 295
Repetitive shuttling of a motor protein on DNA
Myong, S., Rasnik, I., Joo, C., Lohman, T. M., & Ha, T. (2005) · Nature · doi:10.1038/nature04049 · Cited by 267
Cited by
Reddy, L. H., Arias, J. L., Nicolas, J., & Couvreur, P. (2012) · Chemical Reviews · doi:10.1021/cr300068p · Cited by 2,010
Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to Applications
Shi, J., Votruba, A. R., Farokhzad, O. C., & Langer, R. (2010) · Nano Letters · doi:10.1021/nl102184c · Cited by 1,612
Self-citationSurface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles
Sperling, R. A., & Parak, W. J. (2010) · Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences · doi:10.1098/rsta.2009.0273 · Cited by 1,601
Song, S., Wang, L., Li, J., Fan, C., & Zhao, J. (2008) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2007.12.004 · Cited by 1,434
Nanoparticle-based theranostic agents
Xie, J., Lee, S., & Chen, X. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.07.009 · Cited by 1,422
Nanomaterials for Theranostics: Recent Advances and Future Challenges
Lim, E.-K., Kim, T., Paik, S., Haam, S., Huh, Y.-M., & Lee, K. (2015) · Chemical Reviews · doi:10.1021/cr300213b · Cited by 1,233
Bioconjugated quantum dots for in vivo molecular and cellular imaging☆
SMITH, A., DUAN, H., MOHS, A., & NIE, S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.015 · Cited by 1,193
A Molecular Imaging Primer: Modalities, Imaging Agents, and Applications
James, M. L., & Gambhir, S. S. (2012) · Physiological Reviews · doi:10.1152/physrev.00049.2010 · Cited by 1,140
Nanoparticles for Cancer Therapy: Current Progress and Challenges
Gavas, S., Quazi, S., & Karpiński, T. M. (2021) · Nanoscale Research Letters · doi:10.1186/s11671-021-03628-6 · Cited by 1,069
Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by Fluorescence
Chinen, A. B., Guan, C. M., Ferrer, J. R., Barnaby, S. N., Merkel, T. J., & Mirkin, C. A. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00321 · Cited by 1,032
Kim, J., Piao, Y., & Hyeon, T. (2009) · Chem. Soc. Rev. · doi:10.1039/b709883a · Cited by 1,024
Near-infrared fluorescence: application to in vivo molecular imaging
Hilderbrand, S. A., & Weissleder, R. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.09.029 · Cited by 1,023
Designing multifunctional quantum dots for bioimaging, detection, and drug delivery
Zrazhevskiy, P., Sena, M., & Gao, X. (2010) · Chemical Society Reviews · doi:10.1039/b915139g · Cited by 997
Quantum dots: bright and versatile in vitro and in vivo fluorescence imaging biosensors
Wegner, K. D., & Hildebrandt, N. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00532e · Cited by 984
Yao, J., Yang, M., & Duan, Y. (2014) · Chemical Reviews · doi:10.1021/cr200359p · Cited by 944
Toxicity and Environmental Risks of Nanomaterials: Challenges and Future Needs
RAY, P. C., YU, H., & FU, P. P. (2009) · Journal of Environmental Science and Health, Part C · doi:10.1080/10590500802708267 · Cited by 936
Nanomaterials: Applications in Cancer Imaging and Therapy
Barreto, J. A., O’Malley, W., Kubeil, M., Graham, B., Stephan, H., & Spiccia, L. (2011) · Advanced Materials · doi:10.1002/adma.201100140 · Cited by 907
Targeting Strategies for Multifunctional Nanoparticles in Cancer Imaging and Therapy
Yu, M. K., Park, J., & Jon, S. (2012) · Theranostics · doi:10.7150/thno.3463 · Cited by 883
Self-citationAptamers and Their Biological Applications
Song, K.-M., Lee, S., & Ban, C. (2012) · Sensors · doi:10.3390/s120100612 · Cited by 821
Innovative approaches for cancer treatment: current perspectives and new challenges
Pucci, C., Martinelli, C., & Ciofani, G. (2019) · ecancermedicalscience · doi:10.3332/ecancer.2019.961 · Cited by 814
Cancer active targeting by nanoparticles: a comprehensive review of literature
Bazak, R., Houri, M., El Achy, S., Kamel, S., & Refaat, T. (2015) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1767-3 · Cited by 756
Hildebrandt, N., Spillmann, C. M., Algar, W. R., Pons, T., Stewart, M. H., Oh, E., Susumu, K., Díaz, S. A., Delehanty, J. B., & Medintz, I. L. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00030 · Cited by 730
Kim, D., Jeong, Y. Y., & Jon, S. (2010) · ACS Nano · doi:10.1021/nn901877h · Cited by 726
Self-citationZhou, J., Yang, Y., & Zhang, C.-Y. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00049 · Cited by 704
Yu, M. K., Jeong, Y. Y., Park, J., Park, S., Kim, J. W., Min, J. J., Kim, K., & Jon, S. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200800857 · Cited by 615
Self-citationNimjee, S. M., White, R. R., Becker, R. C., & Sullenger, B. A. (2017) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104558 · Cited by 607
The Chemical Biology of Aptamers
Mayer, G. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200804643 · Cited by 592
Zheng, M., Liu, S., Li, J., Qu, D., Zhao, H., Guan, X., Hu, X., Xie, Z., Jing, X., & Sun, Z. (2014) · Advanced Materials · doi:10.1002/adma.201306192 · Cited by 588
Quantum dots: synthesis, bioapplications, and toxicity
Valizadeh, A., Mikaeili, H., Samiei, M., Farkhani, S. M., Zarghami, N., kouhi, M., Akbarzadeh, A., & Davaran, S. (2012) · Nanoscale Research Letters · doi:10.1186/1556-276x-7-480 · Cited by 575
Nucleic Acid Based Molecular Devices
Krishnan, Y., & Simmel, F. C. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.200907223 · Cited by 572
Quantum dot-based resonance energy transfer and its growing application in biology
Medintz, I. L., & Mattoussi, H. (2009) · Phys. Chem. Chem. Phys. · doi:10.1039/b813919a · Cited by 569
Tang, J., Kong, B., Wu, H., Xu, M., Wang, Y., Wang, Y., Zhao, D., & Zheng, G. (2013) · Advanced Materials · doi:10.1002/adma.201303124 · Cited by 567
Cancer treatment therapies: traditional to modern approaches to combat cancers
Kaur, R., Bhardwaj, A., & Gupta, S. (2023) · Molecular Biology Reports · doi:10.1007/s11033-023-08809-3 · Cited by 561
Molecular Imaging with Theranostic Nanoparticles
Jokerst, J. V., & Gambhir, S. S. (2011) · Accounts of Chemical Research · doi:10.1021/ar200106e · Cited by 548
Algar, W. R., Tavares, A. J., & Krull, U. J. (2010) · Analytica Chimica Acta · doi:10.1016/j.aca.2010.05.026 · Cited by 511
Meta-analysis of cellular toxicity for cadmium-containing quantum dots
Oh, E., Liu, R., Nel, A., Gemill, K. B., Bilal, M., Cohen, Y., & Medintz, I. L. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2015.338 · Cited by 502
Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine
Zhang, X.-Q., Xu, X., Bertrand, N., Pridgen, E., Swami, A., & Farokhzad, O. C. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.005 · Cited by 487
Self-citationSemiconductor Quantum Dots in Chemical Sensors and Biosensors
Frasco, M. F., & Chaniotakis, N. (2009) · Sensors · doi:10.3390/s90907266 · Cited by 481
Self-Assembled Targeted Nanoparticles: Evolution of Technologies and Bench to Bedside Translation
Shi, J., Xiao, Z., Kamaly, N., & Farokhzad, O. C. (2011) · Accounts of Chemical Research · doi:10.1021/ar200054n · Cited by 476
Self-citationQuantum dots as a platform for nanoparticle drug delivery vehicle design
Probst, C. E., Zrazhevskiy, P., Bagalkot, V., & Gao, X. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.036 · Cited by 466
Self-citationBiodistribution, Clearance, and Long‐Term Fate of Clinically Relevant Nanomaterials
Bourquin, J., Milosevic, A., Hauser, D., Lehner, R., Blank, F., Petri‐Fink, A., & Rothen‐Rutishauser, B. (2018) · Advanced Materials · doi:10.1002/adma.201704307 · Cited by 461
Song, J., Zhou, J., & Duan, H. (2012) · Journal of the American Chemical Society · doi:10.1021/ja305154a · Cited by 438
Degradability and Clearance of Inorganic Nanoparticles for Biomedical Applications
Yang, G., Phua, S. Z. F., Bindra, A. K., & Zhao, Y. (2019) · Advanced Materials · doi:10.1002/adma.201805730 · Cited by 436
New Generation of Multifunctional Nanoparticles for Cancer Imaging and Therapy
Park, K., Lee, S., Kang, E., Kim, K., Choi, K., & Kwon, I. C. (2009) · Advanced Functional Materials · doi:10.1002/adfm.200801655 · Cited by 432
In vivo Quantum‐Dot Toxicity Assessment
Hauck, T. S., Anderson, R. E., Fischer, H. C., Newbigging, S., & Chan, W. C. W. (2010) · Small · doi:10.1002/smll.200900626 · Cited by 428
Layer-by-Layer Assembled Gold Nanoparticles for siRNA Delivery
Elbakry, A., Zaky, A., Liebl, R., Rachel, R., Goepferich, A., & Breunig, M. (2009) · Nano Letters · doi:10.1021/nl9003865 · Cited by 425
DNA-Mediated Homogeneous Binding Assays for Nucleic Acids and Proteins
Zhang, H., Li, F., Dever, B., Li, X.-F., & Le, X. C. (2013) · Chemical Reviews · doi:10.1021/cr300340p · Cited by 415
Röthlisberger, P., & Hollenstein, M. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.04.007 · Cited by 413
Core–shell quantum dots: Properties and applications
Vasudevan, D., Gaddam, R. R., Trinchi, A., & Cole, I. (2015) · Journal of Alloys and Compounds · doi:10.1016/j.jallcom.2015.02.102 · Cited by 412
Supramolecular cancer nanotheranostics
Zhou, J., Rao, L., Yu, G., Cook, T. R., Chen, X., & Huang, F. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00011f · Cited by 411
Theranostic applications of nanoparticles in cancer
Ahmed, N., Fessi, H., & Elaissari, A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.010 · Cited by 409
Analytical methods to assess nanoparticle toxicity
Marquis, B. J., Love, S. A., Braun, K. L., & Haynes, C. L. (2009) · The Analyst · doi:10.1039/b818082b · Cited by 406
Chen, Y., Pullambhatla, M., Foss, C. A., Byun, Y., Nimmagadda, S., Senthamizhchelvan, S., Sgouros, G., Mease, R. C., & Pomper, M. G. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1357 · Cited by 388
Application of semiconductor quantum dots in bioimaging and biosensing
Martynenko, I. V., Litvin, A. P., Purcell-Milton, F., Baranov, A. V., Fedorov, A. V., & Gun'ko, Y. K. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb01425b · Cited by 382
Surface engineering of inorganic nanoparticles for imaging and therapy
Nam, J., Won, N., Bang, J., Jin, H., Park, J., Jung, S., Jung, S., Park, Y., & Kim, S. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.015 · Cited by 382
Biju, V., Itoh, T., & Ishikawa, M. (2010) · Chemical Society Reviews · doi:10.1039/b926512k · Cited by 372
Reversible Cell‐Specific Drug Delivery with Aptamer‐Functionalized Liposomes
Cao, Z., Tong, R., Mishra, A., Xu, W., Wong, G. C. L., Cheng, J., & Lu, Y. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200901452 · Cited by 372
Dai, Q., Walkey, C., & Chan, W. C. W. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201309464 · Cited by 371
Nanoparticle Technologies for Cancer Therapy
Alexis, F., Pridgen, E. M., Langer, R., & Farokhzad, O. C. (2010) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-00477-3_2 · Cited by 364
Self-citationSemiconductor Quantum Dots in Bioanalysis: Crossing the Valley of Death
Algar, W. R., Susumu, K., Delehanty, J. B., & Medintz, I. L. (2011) · Analytical Chemistry · doi:10.1021/ac201331r · Cited by 347
Bawarski, W. E., Chidlowsky, E., Bharali, D. J., & Mousa, S. A. (2008) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.06.002 · Cited by 337
Nucleic Acid Conjugated Nanomaterials for Enhanced Molecular Recognition
Wang, H., Yang, R., Yang, L., & Tan, W. (2009) · ACS Nano · doi:10.1021/nn9006303 · Cited by 329
Nanotechnology for Early Cancer Detection
Choi, Y.-E., Kwak, J.-W., & Park, J. W. (2010) · Sensors · doi:10.3390/s100100428 · Cited by 329
Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer
Savla, R., Taratula, O., Garbuzenko, O., & Minko, T. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.02.015 · Cited by 314
Wang, A. Z., Bagalkot, V., Vasilliou, C. C., Gu, F., Alexis, F., Zhang, L., Shaikh, M., Yuet, K., Cima, M. J., Langer, R., et al. (2008) · ChemMedChem · doi:10.1002/cmdc.200800091 · Cited by 312
Self-citationUltrasmall inorganic nanoparticles: State-of-the-art and perspectives for biomedical applications
Zarschler, K., Rocks, L., Licciardello, N., Boselli, L., Polo, E., Garcia, K. P., De Cola, L., Stephan, H., & Dawson, K. A. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2016.02.019 · Cited by 303
Polymer‐Coated Nanoparticles: A Universal Tool for Biolabelling Experiments
Zhang, F., Lees, E., Amin, F., Rivera_Gil, P., Yang, F., Mulvaney, P., & Parak, W. J. (2011) · Small · doi:10.1002/smll.201100608 · Cited by 297
Molecular diagnostic and drug delivery agents based on aptamer-nanomaterial conjugates
Lee, J. H., Yigit, M. V., Mazumdar, D., & Lu, Y. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.003 · Cited by 293
Hwang, D. W., Ko, H. Y., Lee, J. H., Kang, H., Ryu, S. H., Song, I. C., Lee, D. S., & Kim, S. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.069880 · Cited by 293
Nanomaterials for Photo-Based Diagnostic and Therapeutic Applications
Menon, J. U., Jadeja, P., Tambe, P., Vu, K., Yuan, B., & Nguyen, K. T. (2013) · Theranostics · doi:10.7150/thno.5327 · Cited by 284
Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy
Zhi, D., Yang, T., Yang, J., Fu, S., & Zhang, S. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.11.027 · Cited by 283
Liu, X., Freeman, R., Golub, E., & Willner, I. (2011) · ACS Nano · doi:10.1021/nn202799d · Cited by 274
Quantum dots, lighting up the research and development of nanomedicine
Wang, Y., & Chen, L. (2011) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2010.12.006 · Cited by 273
Nanotechnology and aptamers: applications in drug delivery
Levy-Nissenbaum, E., Radovic-Moreno, A. F., Wang, A. Z., Langer, R., & Farokhzad, O. C. (2008) · Trends in Biotechnology · doi:10.1016/j.tibtech.2008.04.006 · Cited by 270
Self-citationNucleic acid aptamers in cancer research, diagnosis and therapy
Ma, H., Liu, J., Ali, M. M., Mahmood, M. A. I., Labanieh, L., Lu, M., Iqbal, S. M., Zhang, Q., Zhao, W., & Wan, Y. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00357h · Cited by 265
Structure and function of nanoparticle–protein conjugates
Aubin-Tam, M.-E., & Hamad-Schifferli, K. (2008) · Biomedical Materials · doi:10.1088/1748-6041/3/3/034001 · Cited by 264
Aptamer Nanomedicine for Cancer Therapeutics: Barriers and Potential for Translation
Lao, Y.-H., Phua, K. K. L., & Leong, K. W. (2015) · ACS Nano · doi:10.1021/nn507494p · Cited by 259
Aptamers: Active Targeting Ligands for Cancer Diagnosis and Therapy
Wu, X., Chen, J., Wu, M., & Zhao, J. X. (2015) · Theranostics · doi:10.7150/thno.10257 · Cited by 258
Conjugated Polymer Nanoparticles for Drug Delivery and Imaging
Feng, X., Lv, F., Liu, L., Tang, H., Xing, C., Yang, Q., & Wang, S. (2010) · ACS Applied Materials & Interfaces · doi:10.1021/am100435k · Cited by 256
Engineering Nanocomposite Materials for Cancer Therapy
Minelli, C., Lowe, S. B., & Stevens, M. M. (2010) · Small · doi:10.1002/smll.201000523 · Cited by 255
Cancer‐Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery
Vaughan, H. J., Green, J. J., & Tzeng, S. Y. (2020) · Advanced Materials · doi:10.1002/adma.201901081 · Cited by 255
Quantum dot-based theranostics
Ho, Y.-P., & Leong, K. W. (2010) · Nanoscale · doi:10.1039/b9nr00178f · Cited by 253
Aptamer-guided nanomedicines for anticancer drug delivery
Alshaer, W., Hillaireau, H., & Fattal, E. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.09.011 · Cited by 187
Recent advances in theranostic polymeric nanoparticles for cancer treatment: A review
Indoria, S., Singh, V., & Hsieh, M.-F. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119314 · Cited by 168
The potential of magneto-electric nanocarriers for drug delivery
Kaushik, A., Jayant, R. D., Sagar, V., & Nair, M. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.933803 · Cited by 113
ScFv‐Decorated PEG‐PLA‐Based Nanoparticles for Enhanced siRNA Delivery to Her2+ Breast Cancer
Dou, S., Yang, X., Xiong, M., Sun, C., Yao, Y., Zhu, Y., & Wang, J. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201400037 · Cited by 39
Metadata
- Authors
- Bagalkot, V., Zhang, L., Levy-Nissenbaum, E., Jon, S., Kantoff, P. W., Langer, R., & Farokhzad, O. C.
- Venue
- Nano Letters
- Publisher
- American Chemical Society (ACS)
- Published
- 2007-09-14
- Volume
- 7
- Issue
- 10
- Pages
- 3065-3070
- ISSN
- 1530-6984 (ISSN-L)
- 1530-6992
- OpenAlex
- W2062498920
- Cited by
- 1,036
- References
- 15
- FWCI
- 35.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.